COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,649 Articles (22,913 medRxiv, 8,736 bioRxiv)

Most recent first Previous |  Page 1553: Articles 15521-15530  | Next

A COVID-19 Community Vulnerability Index to drive precision policy in the US
Smittenaar, P., Stewart, N., Sutermaster, S., Coome, L., Dibner-Dunlap, A., Jain, M., Caplan, Y., Campigotto, C., Sgaier, S. K.
10.1101/2021.05.19.21257455 — Posted: 2021-05-20
Differential interferon-α subtype immune signatures suppress SARS-CoV-2 infection
Schuhenn, J., Meister, T. L., Todt, D., Bracht, T., Schork, K., Billaud, J.-N., Elsner, C., Heinen, N., Karakoese, Z., Haid, S., Kumar, S., Brunotte, L., Eisenacher, M., Chen, J., Yuan, Z., Pietschmann, T., Wiegmann, B., Beckert, H., Taube, C., Le-Trilling, V. T. K., Trilling, M., Krawczyk, A., Ludwig, S., Sitek, B., Steinmann, E., Dittmer, U., Sutter, K., Pfaender, S.
10.1101/2021.05.20.444757 — Posted: 2021-05-20
A CRISPR/Cas9 genetically engineered organoid biobank reveals essential host factors for coronaviruses
Beumer, J., Geurts, M. H., Lamers, M. M., Puschhof, J., Zhang, J., van der Vaart, J., Mykytyn, A. Z., Breugem, T. I., Riesebosch, S., Schipper, D., van den Doel, P. B., de Lau, W., Pleguezuelos-Manzano, C., Busslinger, G., Haagmans, B. L., Clevers, H.
10.1101/2021.05.20.444952 — Posted: 2021-05-20
4'-Fluorouridine is a broad-spectrum orally efficacious antiviral blocking respiratory syncytial virus and SARS-CoV-2 replication
Sourimant, J., Lieber, C., Aggarwal, M., Cox, R., Wolf, J., Yoon, J.-J., Toots, M., Ye, C., Sticher, Z., Kolykhalov, A. A., Martinez-Sobrido, L., Bluemling, G. R., Natchus, M. G., Painter, G. R., Plemper, R. K.
10.1101/2021.05.19.444875 — Posted: 2021-05-20
Acute SARS-CoV-2 infection is associated with an expansion of bacteria pathogens in the nose including Pseudomonas aeruginosa
Rhoades, N. S., Pinski, A., Monsibais, A. N., Jankeel, A., Doratt, B. M., Cinco, I. R., Ibraim, I., Messaoudi, I.
10.1101/2021.05.20.445008 — Posted: 2021-05-20
An AAV-ie based Vaccine effectively protects against SARS-CoV-2 and Circulating Variants
Zhao, S., Tan, F., Ke, J., Yang, J., Lin, C.-b., Wang, H., zhong, g.
10.1101/2021.05.19.444889 — Posted: 2021-05-20
Alum:CpG adjuvant enables SARS-CoV-2 RBD-induced protection in aged mice and synergistic activation of human elder type 1 immunity
Nanishi, E., Borriello, F., O'Meara, T. R., McGrath, M. E., Saito, Y., Haupt, R. E., Seo, H.-S., van Haren, S. D., Brook, B., Chen, J., Diray-Arce, J., Doss-Gollin, S., De Leon, M., Chew, K., Menon, M., Song, K., Xu, A. Z., Caradonna, T. M., Feldman, J., Hauser, B. M., Schmidt, A. G., Sherman, A. C., Baden, L. R., Ernst, R. K., Dillen, C., Weston, S. M., Johnson, R. M., Hammond, H. L., Mayer, R., Burke, A., Bottazzi, M. E., Hotez, P. J., Strych, U., Chang, A., Yu, J., Barouch, D. H., Dhe-Paganon, S., Zanoni, I., Ozonoff, A., Frieman, M., Levy, O., Dowling, D. J.
10.1101/2021.05.20.444848 — Posted: 2021-05-20
Single-dose AAV-based vaccine induces a high level of neutralizing antibodies and provides long-term protection against SARS-CoV-2 in rhesus macaques
Tong, D., Zhang, M., Yang, Y., Xia, H., Tong, H., Zeng, W., Liu, M., Ma, H., Hu, X., Liu, W., Cai, Y., Yao, Y., Yao, Y., Liu, K., Shan, S., Li, Y., Gao, G., Guo, W., Peng, Y., Chen, S., Rao, J., Zhao, J., Min, J., Zhu, Q., Zheng, Y., Liu, L., Shan, C., Zhong, K., Qiu, Z., Jin, T., Yuan, Z., Xue, T.
10.1101/2021.05.19.444881 — Posted: 2021-05-20
SARS-CoV-2 screening prevalence in educational staff in Berlin, Germany, June-December 2020
Kindzierski, S., van Loon, W., Theuring, J., Hommes, F., Thombansen, E., Boettcher, M., Matthes, H., Roessig, H., Weiger, D., Wiesmann, C., Kurth, T., Valerie, K., Seybold, J., Mockenhaupt, F. P., Gertler, M.
10.1101/2021.05.19.21257452 — Posted: 2021-05-20
Critically ill COVID-19 associated trait genetics reveals CDK6 inhibitors as potential treatment
Klinger, J. E., Ravarani, C. N. J., Bannard, C., Lamparter, M. R. J., Schwinges, A. R. E. C., Cope, J. L., Baukmann, H. A., Schmidt, M. F.
10.1101/2021.05.18.21256584 — Posted: 2021-05-20

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).